William Gross - 22 Jun 2023 Form 4 Insider Report for Heliogen, Inc. (HLGN)

Reporting relationship: 10%+ Owner
Issuer ticker: HLGN
Reported as of: 22 Jun 2023
Net transaction value: -$13,448
SEC form: 4
Accepted by SEC: 23 Jun 2023, 18:33:42 UTC
Prior SEC filing: 16 Jun 2023
Next SEC filing: 20 Dec 2023
Source filing: View source filing
Reporting owner signature: /s/ William Gross

Key filing fact

William Gross filed Form 4 for Heliogen, Inc. (HLGN) on 23 Jun 2023.

Key facts

This page summarizes William Gross's Form 4 filing for Heliogen, Inc. (HLGN).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 23 Jun 2023, 18:33.

Change

Previous filing in this sequence was filed on 16 Jun 2023.
Current net transaction value: -$13,448.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HLGN transaction

Common Stock

Options Exercise

Transaction value: $154,524
Shares: +858,465
Change %: +19%
Price: $0.1800
Shares after: 5,294,077
Date: 22 Jun 2023
Ownership: Direct

HLGN transaction

Common Stock

Sale

Transaction value: $167,972
Shares: -730,311
Change %: -14%
Price: $0.2300
Shares after: 4,563,766
Date: 22 Jun 2023
Ownership: Direct
Footnotes: F1

HLGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 414,363
Date: 22 Jun 2023
Ownership: See footnote
Footnotes: F2

HLGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 16,175
Date: 22 Jun 2023
Ownership: See footnote
Footnotes: F3

HLGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 15,480,443
Date: 22 Jun 2023
Ownership: See footnote
Footnotes: F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HLGN transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -858,465
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 22 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 858,465
Exercise price: $0.1800
Footnotes: F5, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.23 to $0.24, inclusive. Mr. Gross undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold each separate price within the ranges set forth in footnote (1) to this Form 4.

Footnote F2

These shares are held by The Gross Goodstein Living Trust (the "Trust") of which Mr. Gross is a co-trustee. Mr. Gross may be deemed to beneficially own these shares. Mr. Gross disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Footnote F3

These shares are held by Idealab Studio, LLC ("Idealab Studio"), for which Mr. Gross serves as chairman and chief executive officer. The Trust owns a majority of the class of securities of Idealab Studio entitled to elect two managers to Idealab Studio's board of managers. Mr. Gross may be deemed to beneficially own these shares. Mr. Gross disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Footnote F4

These shares are held by Idealab Holdings, LLC ("Idealab Holdings"), which is a wholly owned subsidiary of Idealab, a California corporation ("Idealab"). Idealab is managed by a board of directors (the "Idealab Board") including Mr. Gross. Mr. Gross may be deemed to beneficially own these shares. Mr. Gross disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Footnote F5

The options vested and became exercisable in equal monthly installments commencing December 21, 2020, subject to Mr. Gross's continuous service which ceased effective February 5, 2023.

Footnote F6

The options were exercisable through the indicated expiration date pursuant to an extension granted by the Issuer. The original expiration date was approximately 10 years from the initial vesting date of options with the same exercise price.